Finzati - Logo
MEDP logo

Medpace Holdings, Inc.

MEDP • Medical - Diagnostics & Research
$591.29
▼ -2.10 (-0.35%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$17.30B
Growth
23.3%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 17.8%Positive revenue growth · 28.8%Positive free cash flow · 23.64Consistent free cash flow · 5/5Manageable debt level · 0.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$591.29
Change-0.35%
Market Cap$17.30B
52W Range373.00 - 677.90
Beta1.15
Gross Margin30.06%
Oper. Margin21.14%
Profit Margin17.83%
Debt/Eq0.55
Current Ratio0.74
Quick Ratio0.74
Revenue 5Y23.28%

Investment DNA

How strong this company looks for long-term investors

76
out of 100
Business Quality
Margins, moat, returns
87/100
Financial Strength
Debt, cash, stability
40/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
35/100
Why this score▼
Stable or improving margins · 17.8%Positive revenue growth · 28.8%Positive free cash flow · 23.64Consistent free cash flow · 5/5Manageable debt level · 0.55Expensive earnings multiple · 35.91

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-24
Low
$400.00
Mean
$536.22
Median
$539.00
High
$620.00

Company Overview

IPO: 8/11/2016
Industry: Medical - Diagnostics & Research
P/B i: 35.29
Debt / Equity i: 0.55
Operating Margin: 21.14%
Net Margin: 17.83%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.55
Current Ratio: 0.74
Quick Ratio: 0.74
Status: Moderate

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Carley Brian T
Transaction: 06/30/2026
SELL
Change
-36
Price
Not reported
Filing
07/02/2026
Type
SELL
Carley Brian T
Transaction: 06/30/2026
BUY
Change
+36
Price
Not reported
Filing
07/02/2026
Type
BUY
McCarthy Cornelius P. III
Transaction: 06/30/2026
SELL
Change
-28
Price
Not reported
Filing
07/02/2026
Type
SELL